What is Active Motif?
Headquartered in Carlsbad, California, Active Motif operates as a critical infrastructure provider for the life sciences industry. The company specializes in the development and distribution of high-precision tools, including advanced antibodies, recombinant proteins, and specialized enzymes designed to facilitate complex gene regulation studies. Through its rigorous focus on epigenetics, Active Motif serves as a vital partner for academic institutions and pharmaceutical organizations alike, providing the foundational materials necessary for breakthroughs in molecular biology and therapeutic discovery. Its market position is defined by a commitment to technical excellence and the delivery of high-quality reagents that meet the stringent demands of modern laboratory environments.
How much funding has Active Motif raised?
Active Motif has raised a total of $2.2M across 2 funding rounds:
Debt
$1M
Debt
$1.2M
Debt (2020): $1M with participation from PPP
Debt (2021): $1.2M led by PPP
Key Investors in Active Motif
PPP
Public-Private Partnership
What's next for Active Motif?
With the recent influx of capital, Active Motif is well-positioned to expand its operational footprint and enhance its product pipeline. The strategic deployment of these funds will likely focus on scaling manufacturing capabilities to meet the rising demand for epigenetic research tools. Furthermore, the company is expected to prioritize the integration of new recombinant technologies, which will serve to broaden its competitive advantage in the biotechnology market. As the firm navigates its current growth trajectory, the emphasis will remain on maintaining its reputation for reliability while exploring new frontiers in gene regulation research, ultimately driving long-term value for its stakeholders and the broader scientific community.
See full Active Motif company page
